Adamas Pharmaceuticals Inc (ADMS) Return on Assets ROA from the third quarter of 2021 to third quarter of 2020 and for the year 2021, Average High and Low, Fundamental Ratios from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Adamas Pharmaceuticals Inc  (NASDAQ: ADMS)


Adamas Pharmaceuticals Inc's ROA from the third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Adamas Pharmaceuticals Inc's ROA in the third quarter of 2021?
Adamas Pharmaceuticals Inc recorded a cumulative net loss of $-63 million during 12 months ending in the third quarter of 2021, resulting in a negative return on assets (ROA) of -44.88%.

However, within the Healthcare sector 651 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2021 from 4234 to 4304.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Total Assets Change 9.75 % 15.11 % 20.16 % -25.81 % -26.03 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -63 -55 -53 -57 -62
Return On Assets (TTM) -44.88 % -40.32 % -40.42 % -45.89 % -46.1 %
ADMS's Total Ranking # 4304 # 4234 # 4128 # 4613 # 4083
Total Assets (TTM) in million 138 145 163 113 126
Seq. Total Assets Change -4.61 % -11.22 % 43.77 % -9.86 % 0.04 %
Seq. Net Income Change - - - - -

ADMS's 5 Years Annual ROA >> Back to ADMS Management Effectiveness >> Compare ADMS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 296
Sector # 652
Overall # 4186

Return On Assets Statistics
High Average Low
6.77 %
-40.92 %
-59.49 %
(Dec 31 2014)   (Dec 31 2017)





Financial Statements
Adamas Pharmaceuticals Inc's Assets $ 138 million ADMS's Balance sheet
Adamas Pharmaceuticals Inc's Income $ -20 million Quarterly ADMS's Income Statement
ADMS's Income by Division See ADMS's Income by Division



Annual Return On Assets (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016
Y / Y Total Assets Change -25.81 % -34.94 % 26.12 % 30.67 % 10.66 %
Total Assets in million 113 153 235 186 142
Y / Y Net Income Change - - - - -
Net Income in million -57 -105 -131 -89 -60
Annual Return On Assets -50.65 % -68.85 % -55.79 % -48.07 % -42.15 %

ADMS's 5 Years Annual ROA >> Back to ADMS Management Effectiveness >> Compare ADMS ROA to its Competitors



More Return On Assets Ratios
ADMS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ADMS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ADMS's Competitors
Subscribers only: Roa for Adamas Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Assets for ADMS's Customers

You may also want to know
ADMS's Roi ADMS's Inventory Turnover Ratio ADMS's Growth Rates ADMS's Dividend Comparisons
ADMS's Profitability Ratios ADMS's Asset Turnover Ratio ADMS's Dividend Growth
ADMS's Roe ADMS's Valuation Ratios ADMS's Financial Strength Ratios ADMS's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2021, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:25+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.